BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 24870816)

  • 1. Podocyte autophagic activity plays a protective role in renal injury and delays the progression of podocytopathies.
    Zeng C; Fan Y; Wu J; Shi S; Chen Z; Zhong Y; Zhang C; Zen K; Liu Z
    J Pathol; 2014 Oct; 234(2):203-13. PubMed ID: 24870816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced podocyte expression of alpha3beta1 integrins and podocyte depletion in patients with primary focal segmental glomerulosclerosis and chronic PAN-treated rats.
    Chen CA; Hwang JC; Guh JY; Chang JM; Lai YH; Chen HC
    J Lab Clin Med; 2006 Feb; 147(2):74-82. PubMed ID: 16459165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In situ evaluation of podocytes in patients with focal segmental glomerulosclerosis and minimal change disease.
    da Silva CA; Monteiro MLGDR; Araújo LS; Urzedo MG; Rocha LB; Dos Reis MA; Machado JR
    PLoS One; 2020; 15(11):e0241745. PubMed ID: 33147279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cytoprotective role of autophagy in puromycin aminonucleoside treated human podocytes.
    Kang YL; Saleem MA; Chan KW; Yung BY; Law HK
    Biochem Biophys Res Commun; 2014 Jan; 443(2):628-34. PubMed ID: 24333414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signal regulatory protein α protects podocytes through promoting autophagic activity.
    Li L; Liu Y; Li S; Yang R; Zeng C; Rong W; Liang H; Zhang M; Zhu X; Kidder K; Liu Y; Liu Z; Zen K
    JCI Insight; 2019 Mar; 5(9):. PubMed ID: 30888336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of urinary angiotensinogen as a marker of podocyte injury in proteinuric nephropathies.
    Eriguchi M; Yotsueda R; Torisu K; Kawai Y; Hasegawa S; Tanaka S; Noguchi H; Masutani K; Kitazono T; Tsuruya K
    Am J Physiol Renal Physiol; 2016 Feb; 310(4):F322-33. PubMed ID: 26632605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NADPH oxidase-derived ROS contributes to upregulation of TRPC6 expression in puromycin aminonucleoside-induced podocyte injury.
    Wang Z; Wei X; Zhang Y; Ma X; Li B; Zhang S; Du P; Zhang X; Yi F
    Cell Physiol Biochem; 2009; 24(5-6):619-26. PubMed ID: 19910702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The novel involvement of podocyte autophagic activity in the pathogenesis of lupus nephritis.
    Jin J; Ye M; Zhao L; Zou W; Shen W; Zhang H; Gong J; He Q
    Histol Histopathol; 2018 Aug; 33(8):803-814. PubMed ID: 29446059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrastructural features and expression of cytoskeleton proteins of podocyte from patients with minimal change disease and focal segmental glomerulosclerosis.
    Shi SF; Wang SX; Zhang YK; Zhao MH; Zou WZ
    Ren Fail; 2008; 30(5):477-83. PubMed ID: 18569926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of TRPC6 ion channels in podocytes - Implications for focal segmental glomerulosclerosis and acquired forms of proteinuric diseases.
    Szabó T; Ambrus L; Zákány N; Balla G; Bíró T
    Acta Physiol Hung; 2015 Sep; 102(3):241-51. PubMed ID: 26551740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced podocyte expression of alpha3beta1 integrins and podocyte depletion in patients with primary focal segmental glomerulosclerosis and chronic PAN-treated rats.
    Celik Y; Celik F
    Transl Res; 2006 Jul; 148(1):46. PubMed ID: 16887498
    [No Abstract]   [Full Text] [Related]  

  • 12. Podocyte expression of nonmuscle myosin heavy chain-IIA decreases in idiopathic nephrotic syndrome, especially in focal segmental glomerulosclerosis.
    Miura K; Kurihara H; Horita S; Chikamoto H; Hattori M; Harita Y; Tsurumi H; Kajiho Y; Sawada Y; Sasaki S; Igarashi T; Kunishima S; Sekine T
    Nephrol Dial Transplant; 2013 Dec; 28(12):2993-3003. PubMed ID: 24042022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluvastatin ameliorates podocyte injury in proteinuric rats via modulation of excessive Rho signaling.
    Shibata S; Nagase M; Fujita T
    J Am Soc Nephrol; 2006 Mar; 17(3):754-64. PubMed ID: 16452496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasminogenuria is associated with podocyte injury, edema, and kidney dysfunction in incident glomerular disease.
    Egerman MA; Wong JS; Runxia T; Mosoyan G; Chauhan K; Reyes-Bahamonde J; Anandakrishnan N; Wong NJ; Bagiella E; Salem F; Meliambro K; Li H; Azeloglu EU; Coca SG; Campbell KN; Raij L
    FASEB J; 2020 Dec; 34(12):16191-16204. PubMed ID: 33070369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Connective tissue growth factor modulates podocyte actin cytoskeleton and extracellular matrix synthesis and is induced in podocytes upon injury.
    Fuchshofer R; Ullmann S; Zeilbeck LF; Baumann M; Junglas B; Tamm ER
    Histochem Cell Biol; 2011 Sep; 136(3):301-19. PubMed ID: 21814837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of microRNA-30 facilitates podocyte injury and is prevented by glucocorticoids.
    Wu J; Zheng C; Fan Y; Zeng C; Chen Z; Qin W; Zhang C; Zhang W; Wang X; Zhu X; Zhang M; Zen K; Liu Z
    J Am Soc Nephrol; 2014 Jan; 25(1):92-104. PubMed ID: 24029422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome.
    Koshikawa M; Mukoyama M; Mori K; Suganami T; Sawai K; Yoshioka T; Nagae T; Yokoi H; Kawachi H; Shimizu F; Sugawara A; Nakao K
    J Am Soc Nephrol; 2005 Sep; 16(9):2690-701. PubMed ID: 15987752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melanocortin therapy ameliorates podocytopathy and proteinuria in experimental focal segmental glomerulosclerosis involving a podocyte specific non-MC1R-mediated melanocortinergic signaling.
    Qiao Y; Wang P; Chang M; Chen B; Ge Y; Malhotra DK; Dworkin LD; Gong R
    Clin Sci (Lond); 2020 Apr; 134(7):695-710. PubMed ID: 32167144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sirt6 deficiency exacerbates podocyte injury and proteinuria through targeting Notch signaling.
    Liu M; Liang K; Zhen J; Zhou M; Wang X; Wang Z; Wei X; Zhang Y; Sun Y; Zhou Z; Su H; Zhang C; Li N; Gao C; Peng J; Yi F
    Nat Commun; 2017 Sep; 8(1):413. PubMed ID: 28871079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Podocyte protection by darbepoetin: preservation of the cytoskeleton and nephrin expression.
    Eto N; Wada T; Inagi R; Takano H; Shimizu A; Kato H; Kurihara H; Kawachi H; Shankland SJ; Fujita T; Nangaku M
    Kidney Int; 2007 Aug; 72(4):455-63. PubMed ID: 17457371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.